Arcutis Biotherapeutics, Inc.
ARQT
Classement en actions
#3977
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Prix de l'action
$32.88
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$4.13B
Changement (1 jour)
3.11%
Changement (1 an)
59.32%
Pays
US
Échange Arcutis Biotherapeutics, Inc. (ARQT)
Catégorie
Healthcare
Historique des divisions d’actions pour Arcutis Biotherapeutics, Inc. (ARQT)
L’action Arcutis Biotherapeutics, Inc. (symbole : ARQT) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action ARQT achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions ARQT.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action ARQT achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions ARQT.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| Pas assez de données pour les dates fournies. | |||
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|